Skip to main content
Premium Trial:

Request an Annual Quote

Waters: Wei Jiang

Waters has appointed Wei Jiang to its board of directors. Jiang currently serves as executive vice president and president of Bayer Pharmaceuticals Region China & APAC; and president of Bayer Group Greater China. He previously held various senior positions at AstraZeneca, culminating in his role as senior vice president, China operations. Prior to that, Jiang served as managing director, China operations, at Guidant; and in various roles at Eli Lilly & Company including marketing director of China operations. He currently serves on the boards of the China Red Cross and R&D Based Pharmaceutical Association.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.